| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 220,028 | 224,005 | 222,209 | 225,770 | | Cost of Revenue | 67,659 | 72,263 | 74,566 | 77,337 | | | Gross Profit | 152,369 | 151,742 | 147,643 | 148,433 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 123,471 | 133,746 | 130,887 | 137,946 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,848 | 12,896 | 13,942 | 13,347 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,050 | 5,100 | 2,814 | (2,860) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,215 | 13,881 | (30,480) | 590 | | Earnings Before Interest And Taxes | 16,265 | 18,981 | (27,666) | (2,270) | | Interest Expense | 13,679 | 13,542 | 13,268 | 5,504 | | Income Before Tax | 2,586 | 5,439 | (40,934) | (7,774) | | Income Tax Expense | 301 | 168 | (18) | 43 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,285 | 5,271 | (40,916) | (7,817) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,285 | 5,271 | (40,916) | (7,817) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,285 | $5,271 | ($40,916) | ($7,817) |
|
0.02% Nasdaq 0.00%
Income Statement
